Carotid artery stiffness, digital endothelial function, and coronary calcium in patients with essential thrombocytosis, free of overt atherosclerotic disease

1Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med 2006; 355: 2452-66. 10.1056/NEJMra063728CampbellPJGreenARThe myeloproliferative disordersN Engl J Med200635524526610.1056/NEJMra06372817151367Open DOISearch in Google Scholar

2Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 2012; 119: 3219-25. 10.1182/ blood-2011-11-394775HasselbalchHCPerspectives on chronic inflammation in essential, thrombocythemia polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?Blood201211932192510.1182/ blood-2011-11-394775Open DOISearch in Google Scholar

3Hasselbalch H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 1990; 34: 291-300.HasselbalchHIdiopathic myelofibrosis: a clinical study of 80 patientsAm J Hematol19903429130010.1002/ajh.28303404112195869Search in Google Scholar

4Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica. 2010; 95: 1216-20. 10.3324/haematol.2009.020412KristinssonS YLandgrenOSamuelssonJBjörkholmMGoldinLRAutoimmunity and the risk of myeloproliferative neoplasmsHaematologica20109512162010.3324/haematol.2009.020412289504920053870Open DOISearch in Google Scholar

5Koschmieder S, Mughal TI, Hasselbalch HC, Barosi G, Valent P, Kiladjian JJ, et al. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both. Leukemia 2016; 30:1018-24. 10.1038/leu.2016.12KoschmiederSMughalTIHasselbalchHCBarosiGValentPKiladjianJJet alMyeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothLeukemia20163010182410.1038/leu.2016.1226854026Open DOISearch in Google Scholar

6Fleischman AG. Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm. Mediators Inflamm 2015: 2015: 606819. 10.1155/2015/606819FleischmanAGInflammation as a Driver of Clonal Evolution in Myeloproliferative NeoplasmMediators Inflamm2015201560681910.1155/2015/606819461997426538830Open DOISearch in Google Scholar

7Hermouet S, Bigot-Corbel E, Gardie B. Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation. Mediators Inflamm 2015; 2015:145293. 10.1155/2015/145293HermouetSBigot-CorbelEGardieBPathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic InflammationMediators Inflamm2015201510.1155/2015/145293461995026538820Open DOISearch in Google Scholar

8Sørensen AL, Hasselbalch HC. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Res 2016; 41:27-35. 10.1016/j.leukres.2015.11.017SørensenALHasselbalchHCAntecedent cardiovascular disease and auto-immunity in Philadelphia-negative chronic myeloproliferative neoplasmsLeuk Res201641273510.1016/j.leukres.2015.11.01726718091Open DOISearch in Google Scholar

9Hasselbalch HC, Bjørn ME. MPNs as inflammatory diseases: the evidence, consequences, and perspectives. Mediators Inflamm 2015; 2015: 102476. 10.1155/2015/102476HasselbalchHCBjørnMEMPNs as inflammatory diseases: the evidence, consequences, and perspectivesMediators Inflamm2015201510247610.1155/2015/102476464120026604428Open DOISearch in Google Scholar

10Saif MW, Khan U, Greenberg BR. Cardiovascular manifestations of myeloproliferative disorders: a review of the literature. Hosp Physician 1999; 35: 43-54.SaifMWKhanUGreenbergBRCardiovascular manifestations of myeloproliferative disorders: a review of the literatureHosp Physician1999354354Search in Google Scholar

11Rossi C, Randi L, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocytemia and polycythemia vera. J Intern Med 1998; 244: 49-53.RossiCRandiLZerbinatiPRinaldiVGirolamiAAcute coronary disease in essential thrombocytemia and polycythemia veraJ Intern Med1998244495310.1046/j.1365-2796.1998.00314.x9698024Search in Google Scholar

12Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115–26. 10.1056/NEJM199901143400207RossRAtherosclerosis. An inflammatory diseaseN Engl J Med19993401152610.1056/NEJM199901143400207Open DOISearch in Google Scholar

13Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-12. 10.1038/ni.2001HanssonGKHermanssonAThe immune system in atherosclerosisNat Immunol2011122041210.1038/ni.2001Open DOISearch in Google Scholar

14Landolfi R, Di Gennaro L. Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica 2011; 96: 183-6. 10.3324/haematol.2010.038299LandolfiRDi GennaroLPathophysiology of thrombosis in myeloproliferative neoplasmsHaematologica201196183610.3324/haematol.2010.038299Open DOISearch in Google Scholar

15Fleischman AG, Aichberger KJ, Luty SB, Bumm TG, Petersen CL, Doratotaj S, et al. Tumor necrosis factor-alpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood 2011; 118: 6392-98. 10.1182/blood-2011-04-348144FleischmanAGAichbergerKJLutySBBummTGPetersenCLDoratotajSetalTumor necrosis factor-alpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasmsBlood201111863929810.1182/blood-2011-04-348144Open DOISearch in Google Scholar

16Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-605. 10.1093/ eurheartj/ehl254LaurentSCockcroftJVan BortelLBoutouyriePGiannattasioCHayozDet alEuropean Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applicationsEur Heart J200627258860510.1093/ eurheartj/ehl254Open DOISearch in Google Scholar

17Nuñez F, Martínez-Costa C, Sanchez-Zahonero J, Morata J, Chorro FJ, Brines J. Carotid artery stiffness as an early marker of vascular lesions in children and adolescents with cardiovascular risk factors. Rev Esp Cardiol 2010; 63:1253-60.NuñezFMartínez-CostaCSanchez-ZahoneroJMorataJChorroFJBrinesJCarotid artery stiffness as an early marker of vascular lesions in children and adolescents with cardiovascular risk factorsRev Esp Cardiol20106312536010.1016/S1885-5857(10)70250-4Search in Google Scholar

18Cote AT, Phillips AA, Harris KC, Sandor GGS, Panagiotopoulos C, Devlin AM. Obesity and arterial stiffness in children. Systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2015; 35:1038-44. 10.1161/ ATVBAHA.114.305062CoteATPhillipsAAHarrisKCSandorGGSPanagiotopoulosCDevlin AM. Obesity and arterial stiffness in children. Systematic review and meta-analysisArterioscler Thromb Vasc Biol20153510384410.1161/ ATVBAHA.114.305062Open DOISearch in Google Scholar

19Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, et al. The assessment of endothelial function - from research into clinical practice. Circulation 2012;126: 753-67. 10.1161/ CIRCULATIONAHA.112.093245FlammerAJAndersonTCelermajerDSCreagerMADeanfieldJGanzPet alThe assessment of endothelial function - from research into clinical practiceCirculation20121267536710.1161/ CIRCULATIONAHA.112.093245Open DOISearch in Google Scholar

20Halcox JP, Donald AE, Ellins E, Witte DR, Shipley MJ, Brunner EJ, et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009; 119:1005–12. 10.1161/CIRCULATIONAHA.108.765701HalcoxJPDonaldAEEllinsEWitteDRShipleyMJBrunnerEJet alEndothelial function predicts progression of carotid intima-media thicknessCirculation200911910051210.1161/CIRCULATIONAHA.108.76570119204308Open DOISearch in Google Scholar

21Hecht HS. Coronary artery calcium scanning – past, present and future. JACC Cardiovasc Img 2015; 8: 579-96. 10.1016/j.jcmg.2015.02.006HechtHSCoronary artery calcium scanning – past, present and futureJACC Cardiovasc Img201585799610.1016/j.jcmg.2015.02.00625937196Open DOISearch in Google Scholar

22D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al. General cardiovascular risk profile for use in primary care – the Framingham Heart Study. Circulation 2008; 117: 743-52. 10.1161/ CIRCULATIONAHA.107.699579D’AgostinoRBVasanRSPencinaMJWolfPACobainMMassaroJMet alGeneral cardiovascular risk profile for use in primary care – the Framingham Heart StudyCirculation20081177435210.1161/ CIRCULATIONAHA.107.699579Open DOISearch in Google Scholar

23Availabe at: http:// cvrisk.mvm.ed.ac.uk/calculator/riskcalculator.xls. Accessed: Sep 7, 2016.Availabe athttp:// cvrisk.mvm.ed.ac.uk/calculator/riskcalculator.xlsAccessedSep72016Search in Google Scholar

24Hollander M, Bots ML, Iglesias del Sol A, Koudstaal PJ, Witteman JCM, Grobbee DE, et al. Carotid plaques increase the risk of troke and subtypes of cerebral infarction in asymptomatic elderly – the Rotterdam Study. Circulation 2002; 105: 2872-7.HollanderMBotsMLIglesias del SolAKoudstaalPJWittemanJCMGrobbeeDEet alCarotid plaques increase the risk of troke and subtypes of cerebral infarction in asymptomatic elderly – the Rotterdam StudyCirculation20021052872710.1161/01.CIR.0000018650.58984.75Search in Google Scholar

25Hayashi K, Handa H, Nagasawa S, Okumura A, Moritake K. Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech 1980; 13:175–184.HayashiKHandaHNagasawaSOkumuraAMoritakeK.Stiffness and elastic behavior of human intracranial and extracranial arteriesJ Biomech19801317518410.1016/0021-9290(80)90191-8Search in Google Scholar

26Aloka, ultrasound diagnostic instrument, prosound α7, instruction manual, how to use (volume 2/2) MN 1 – 5369 rev. 9: 140-9.Alokaultrasound diagnostic instrument, prosound α7instruction manual, how to use (volume 2/2) MN 1 – 5369 rev91409Search in Google Scholar

27Agatston AS, Janowitz WR, Hilander FJ, Zusmer RN, Viamonte M, Detrow R. Qunatification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32.AgatstonASJanowitzWRHilanderFJZusmerRNViamonteMDetrowRQunatification of coronary artery calcium using ultrafast computed tomographyJ Am Coll Cardiol1990158273210.1016/0735-1097(90)90282-TSearch in Google Scholar

28Axtell AL, Gomari FA, Cooke JP. Assessing endothelial vasodilator function with the Endo-PAT 2000. J Vis Exp 2010; 44: e2167,10.3791/2167AxtellALGomariFACookeJ P.Assessing endothelial vasodilator function with the Endo-PAT 2000J Vis Exp201044e216710.3791/2167Open DOISearch in Google Scholar

29Arad Y, Spadaro LA, Goodman K, NewsteinD, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Col Cardiol 2000; 36: 1253-60.AradYSpadaroLAGoodmanKNewsteinDGuerciAD.Prediction of coronary events with electron beam computed tomographyJ Am Col Cardiol20003612536010.1016/S0735-1097(00)00872-XSearch in Google Scholar

30Hayashi K, Yamamoto T, Takahara A, Shirai K. Clinical assessment of arterial stiffness with cardio-ankle vascular index: theory and application. J Hypertens 2015; 33: 1742-57. 10.1097/HJH.0000000000000651HayashiKYamamotoTTakaharaAShiraiKClinical assessment of arterial stiffness with cardio-ankle vascular index: theory and applicationJ Hypertens20153317425710.1097/HJH.000000000000065126114836Open DOISearch in Google Scholar

31Blacher J, Pannier B, Guerin A, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570–574.BlacherJPannierBGuerinAMarchaisSJSafarMELondonGMCarotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal diseaseHypertension19983257057410.1161/01.HYP.32.3.570Search in Google Scholar

32Barenbrock M, Kosch M, Joster E, Kisters K, Rahn K, Hausberg M. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 2002; 20:79–84.BarenbrockMKoschMJosterEKistersKRahnKHausbergMReduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantationJ Hypertens200220798410.1097/00004872-200201000-0001211791029Search in Google Scholar

33Dijk JM, Algra A, van der Graff Y, Grobbee DE, Bots ML, SMART study group. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J 2005; 26:1213–1220. 10.1093/eurheartj/ehi254DijkJMAlgraAvan der GraffYGrobbeeDEBotsMLSMART study group. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART studyEur Heart J2005261213122010.1093/eurheartj/ehi25415824075Open DOISearch in Google Scholar

34Celermajer DS. Reliable endothelial function testing : at our fingertips? Circulation 2008, 117: 2428-30. 10.1161/CIRCULATIONAHA.108.775155CelermajerDSReliable endothelial function testing : at our fingertips?Circulation200811724283010.1161/CIRCULATIONAHA.108.77515518474821Open DOISearch in Google Scholar

35Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al.. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008;117: 2467–74. 10.1161/CIRCULATIONAHA.107.748574HamburgNMKeyesMJLarsonMGVasanRSSchnabelRPrydeMMet alCross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart StudyCirculation200811724677410.1161/CIRCULATIONAHA.107.748574273414118458169Open DOISearch in Google Scholar